Fall 2013 Vol. 03 Issue 03
-
Editor's Letter
Cancer Research: Worth Paying ForKevin McLaughlin discusses how one survivor's faith in science underscores the importance of continued funding for cancer research.
by Kevin McLaughlin
-
Your Cancer Guide
Have Cancer, Will TravelWith planning, most patients and survivors can experience the rejuvenation that comes with getting away.
by Hester Hill Schnipper
-
A Clear Vision
Asking the right questions can help patients living with metastatic cancer understand the risks and benefits of recommended treatments and formulate their goals more effectively.
by Charlotte Huff
-
Beyond Survival
As cancer survivor numbers grow and longevity increases, researchers study how to ease symptoms and side effects.
by Melissa Weber
-
More Than a Signature
The informed consent process is designed to ensure that patients understand risks. But new advances involved in genetic testing and tissue donation may make signing on the dotted line more complex than ever.
by Stephen Ornes
-
Sorting Through Information Overload
Help your loved one conquer the mountain of medical and financial information that cancer brings on.
by Michelle Johnston-Fleece
-
Survivor Profile
Betting on ScienceDiagnosed with a rare and incurable blood cancer, Jack Whelan is a passionate booster for research, clinical trials and affordable treatments.
by Betty Russell
-
Yesterday & Today
From Desire to DaisyWhether it was a star turn playing Blanche DuBois or Daisy Werthan, Jessica Tandy sparkled in a tough role. That didn't change after her cancer diagnosis.
by Karen Patterson
-
Q&A
Support in Any LanguagePatient advocate Ivis Febus-Sampayo promotes support services for cancer patients in minority communities.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersOn weighing acupuncture for cancer-related symptoms, getting help while caring for a parent, and having pets during treatment.
-
Get Involved
Sending Get Well WishesJoan A. Smith organizes volunteers' efforts to send cards to cancer patients.
by Maria Wolf
-
In the Moment- Fall 2013
Oscar Llerena, Kimberlee Eshbaugh, Julie Garrabrant.
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
Dealing With Immediate Medical Test ResultsPatients have been entitled to immediate access to medical records and test results for three years as a result of the Cures Act. It has changed how patients and doctors share information.
by Taneia Surles
Empowering Pediatric Cancer PatientsAfter twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
Light at the End of the Tunnel for ASPS PatientsImmunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose